An artificial oxygen carrier, liposome-encapsulated hemoglobin (LEH), protective in a rodent stroke model, was quantitatively evaluated in monkeys. Serial positron emission tomography studies using the steady-state 15 O-gas inhalation method were performed to quantify O 2 metabolism, which was compared based on the infarction extent and immunohistochemical evaluation in 19 monkeys undergoing middle cerebral artery occlusion (3 h), infusion of various LEH doses (n ϭ 11), empty liposome (n ϭ 4), or saline (n ϭ 4) 5 min after the onset of ischemia, and reperfusion for 5 h. There was no significant difference in O 2 metabolism until 3 h after reperfusion, when the cerebral metabolic rate of O 2 (CMRO 2 ) was significantly less suppressed in the cortex [mild suppression in CMRO 2 (71-100%) of preischemic ipsilateral control as in the ischemic penumbra: 64.7 Ϯ 14.3% in empty liposome versus 32.4 Ϯ 7.9% in LEH (2 ml/kg) treatment, P Ͻ 0.05] but not in basal ganglia. Immunohistochemical studies showed a reciprocal expression of microtubular-associated protein II expression in the cortex and LEH deposition in basal ganglia, suggesting the LEH perfusion, but not deposition, afforded the protection. Doseresponse studies revealed that as little as 0.4 ml/kg LEH (24 mg/kg hemoglobin) was effective in preserving CMRO 2 , whereas 2 and 10 ml/kg were protective in significantly reducing the area of infarction as well, by 66 and 56%, respectively, compared with animals receiving saline. CMRO 2 and histological integrity were better preserved early after 3-h occlusion and reperfusion of the middle cerebral artery of monkeys receiving LEH early after onset of ischemia.
method using positron emission tomography (PET) (Takamatsu et al., 2000 (Takamatsu et al., , 2001 Tsukada et al., 2004; Cui et al., 2006) in nonhuman primates undergoing MCA occlusion (MCAO) for 3 h and reperfusion for 5 h, as a simulation of the acute phase of clinical ischemic stroke.
Materials and Methods
The following experiments were approved by the Ethics Committee of the Central Research Laboratory of Hamamatsu Photonics. The animals received humane care as required by the institutional guidelines and the Guide for the Care and Use of Laboratory Animals (Institute of Laboratory Animal Resources, 1996) . All the animals received anesthesia and analgesia throughout the experiments so as not to experience any anxiety or pain, and were euthanized by an overdose of anesthesia at the end of the experiment according to the recommendation of the animal experiment committee.
LEH. LEH (TRM-645; Terumo Co., Ltd., Tokyo, Japan) is a liposome capsule with a mean diameter of 230 nm containing purified hemoglobin from outdated human RBCs (Ogata, 2000) . The liposome capsule is coated with polyethylene glycol to reduce aggregation and prevent capture by the reticuloendothelial cell system, prolonging half-life in the circulation up to 70 h in nonhuman primates (Kaneda et al., 2009) . A previous rheological study showed that LEH has a flow pattern and specific gravity similar to that of plasma (Kawaguchi et al., 2007) . LEH forms a layer between plasma and RBCs after centrifugation at 100,000g for 1 h. O 2 affinity was reduced by coencapsulating inositol hexaphosphate for 2,3-diphosphoglycerate to bring the P 50 O 2 value (partial pressure of O 2 where 50% of hemoglobin is bound to O 2 ) to 40 to 50 mm Hg, higher than that of RBCs (P 50 O 2 ϭ 30 mm Hg). LEH is suspended in saline to a final hemoglobin concentration of 6 g/dl and 20% in volume, which then has reduced viscosity (2 cP) and an O 2 -carrying capacity comparable with human RBCs under physiological conditions (Ogata, 2001; Kaneda et al., 2009) . Empty liposome was prepared exactly as LEH was, except that saline was used to replace hemoglobin to serve as a control solution with the same particle surface characteristics without O 2 -carrying capacity.
Protocols and Animals. Experiments were performed on 19 cynomolgus monkeys (Macaca fascicularis) with a body weight ranging from 3.48 to 6.67 kg (mean weight, 5.28 Ϯ 0.95 kg) purchased from CLEA Japan Inc. (Tokyo, Japan). The monkeys were anesthetized with intramuscular ketamine hydrochloride (10 mg/kg), intubated, immobilized with pancuronium bromide (0.05 mg/kg), ventilated 10 to 15 times/min with a tidal volume of 10 ml/kg and no end-expiratory pressure (Cato; Drä ger Medical, Lü beck, Germany), and maintained on isoflurane (0.6 -0.8%) in an N 2 O/O 2 gas mixture (7:3). The left femoral artery was catheterized to regularly/continuously monitor blood pressure, heart rate, and blood sampling for arterial gases and glucose. MCA was occluded using a transorbital approach (Takamatsu et al., 2000) . In this procedure, after intramuscular atropine sulfate (0.05 mg/kg), the right globe was removed, and a craniotomy was performed superolateral to the optic nerve. The dura mater was opened, and MCAO was performed with two microvascular clips, one on the proximal part of the main MCA trunk and the other distal to the orbitofrontal branch to inhibit collateral circulation. Three hours after MCAO, the clips were removed for reperfusion. After a series of PET scans, monkeys were euthanized 8 h after the start of MCAO, or 5 h after reperfusion of MCA.
Drug Administration. Five minutes after MCAO, the monkeys were randomized to intravenously receive empty liposome (n ϭ 4), saline (n ϭ 4), or LEH at one of three different doses-10 ml/kg (n ϭ 5), 2 ml/kg (n ϭ 3), and 0.4 ml/kg (n ϭ 3)-and MCA reperfusion 3 h later as an acute study. To avoid acute volume load, 10-or 2-ml/kg solution was administered at a rate of 5 ml/min, and 0.4 ml/kg LEH was given as a bolus infusion.
PET Studies. Four consecutive PET scans were performed on each monkey, with the head fixed in a stereotactic apparatus (SFCT-RB-PR-2; Hamamatsu Photonics, Hamamatsu, Japan) placed in the gantry of a high-resolution PET system (Watanabe et al., 1997) (SHR-7700; Hamamatsu Photonics). The first scans (T1) served as preischemic control. The animals were temporarily removed to undergo MCAO and then placed back in the stereotactic apparatus. The second scan was obtained 2 h after the start of MCAO (T2). The third scan was performed immediately after reperfusion or 3 h after MCAO (T3), and the fourth scan was obtained 6 h after MCAO (T4), or 3 h after reperfusion began. After the last PET scan (T4), monkeys were euthanized with an overdose of sodium pentobarbital.
Data Acquisition for O 2 Metabolism. At each time point (T1-T4), cerebral blood flow (CBF), oxygen extraction fraction (OEF), cerebral metabolic rate of O 2 (CMRO 2 ), and cerebral blood volume were assessed using the steady-state 15 O inhalation method (Takamatsu et al., 2000 (Takamatsu et al., , 2001 , two arterial blood samples were taken, one each at the beginning and end of acquisition. These samples were used for determination of radioactivity, hemoglobin concentration, hematocrit, blood gases, plasma glucose, and finally LEHcrit, which required high-speed centrifugation (100,000g) for 1 h.
Data Analysis and Correction for the Presence of LEH. Because CBF and cerebral blood volume determinations are based on the radioactivity of whole blood, 15 CO 2 and 15 CO, respectively, there would be no influence of the presence of LEH on their determinations. Because LEH was expected to remain in the plasma fraction after the onsite centrifugation (7000g, 5 min) and to increase the plasma to whole blood (PL/WB) radioactivity ratio, leading to an underestimation of OEF and CMRO 2 , PET determinations on these variables were dually carried out and compared based on the onsite PL/WB ratio in each scan (T1-T4), as well as on the PL/WB ratio before LEH administration at T1 in each animal.
Region of Interest. The region of interest was fixed to the anatomic area of the cortex and basal ganglia, which were defined in relation to the anatomic map of the monkey brain (Paxinos et al., 2000) and magnetic resonance (MR) images. The PET scan optically sectioned the whole brain into 3.6-mm-thick horizontal slices, each consisting of 1.2 ϫ 1.2 ϫ 3.6 mm voxels (5.2 mm 3 ). In each voxel of the ischemic hemisphere, the measured values of CBF, OEF, and CMRO 2 at each of T2, T3, or T4 were expressed as percentage of the preischemic levels (T n /T 1 ϫ 100%; n ϭ 2-4). Distribution of the measured values was displayed in a histogram for the ischemic hemisphere in consecutive 10% ranges of preischemic values.
Morphological Analysis. After the monkeys were euthanized, the brain of each animal was fixed through transcardiac perfusion with 10% formalin neutral buffer solution, pH 7.4, after saline perfusion at 100 mm Hg. Then the brain was removed, and 12 coronal sections were cut at 2-mm intervals on a brain matrix (MBM-2000C; Bioresearch Center, Nagoya, Japan). Each section was embedded in paraffin wax, and 10-m-thick sections were stained with hematoxylin and eosin (H&E). Early neurological damage (Osborne et al., 1987) was shown by pyknosis, karyorrhexis, karyolysis, and cytoplasmic eosinophilia or loss of hematoxylin affinity. The area of neuronal damage was defined, calculated from the different coronal sections and their anteroposterior coordinates (Garcia et al., 1997) , and integrated using a computerized image analysis system after correcting for brain edema (Swanson et al., 1990) .
Immunohistochemical Studies. Immunohistochemical studies were performed in one animal from each group (LEH 10 ml/kg and saline) to detect microtubular-associated protein II (MAP2) (Pettigrew et al., 1996) and human hemoglobin for LEH; evaluation was performed in a blinded fashion by a neuroanatomist (M.Y.) without knowledge of the study protocol.
Statistics. Data are presented as mean Ϯ S.D. All the data were evaluated by analysis of variance followed by Dunnett's multiple range test if not otherwise indicated. P Ͻ 0.05 was considered statistically significant.
Results
Physiological and Metabolic Parameters. The hemodynamic and metabolic parameters of all the animal groups at preischemic time (T1), 2 h after MCAO (T2), at reperfusion (T3), and 3 h after (T4) are presented in Tables 1 and 2 . Whereas MCAO changed the hemodynamic parameters, LEH treatment did not cause significant alterations in heart rate or mean blood pressure. Three hours after reperfusion (T4), all the hemodynamic parameters in LEH-treated animals returned to preischemic levels. Plasma glucose levels, partial pressure of CO 2 , and partial pressure of O 2 (PO 2 ) remained within normal range throughout the study. Hematocrit varied between 38 and 42%, and total blood O 2 content during ischemia was higher in animals receiving LEH at 2 ml/kg than in those receiving empty liposome or LEH at 0.4 ml/kg. Volume percentage of LEH after high-speed centrifugation (100,000g for 1 h) was dose-dependent: 3.0 Ϯ 0.2% for 10 ml/kg, 0.9 Ϯ 0.1% for 2 ml/kg, and 0.2 Ϯ 0.1% for 0.4 ml/kg. PET 15 O-Gas Study. LEH administration increased the PL/WB radioactivity ratio (Fig. 1A ), leading to a mild (Ϫ8.4 Ϯ 7.0%) but consistent (r 2 ϭ 0.956) underestimation of CMRO 2 regardless of the presence or absence of ischemia. Therefore, the shift of OEF and CMRO 2 values before (T1) and after LEH administration (T2, T3, and T4) in the intact hemisphere was used to correct the respective values in the ischemic hemisphere to offset the estimation error(s). Then, based on the reported degrees of reduction in CBF (Jones et al., 1981) , CMRO 2 (Frykholm et al., 2000) , and morphological change (Tamura et al., 1980) , the distributions of the values of CBF, OEF, and CMRO 2 in the ischemic hemisphere were defined as a severe-to-moderate decrease (Ͻ71%), mild decrease (71 to Ͻ101%), mild increase (101 to Ͻ131%), and moderate-tomarked increase (Յ131%) from preischemic control (T1).
Global Changes in the Hemisphere. Sequential comparisons in CBF, OEF, and CMRO 2 of the ischemic hemisphere (Fig. 1B) in the above ranges between LEH-treated groups (10, 2, and 0.4 ml/kg) and empty liposome-treated controls showed a leftward shift (decrease) of CBF and CMRO 2 2 h after MCAO (T2) despite a rightward shift (increase) of OEF in all without any difference among groups. At reperfusion (T3), the CBF distribution returned to the center with partial hyperemia, OEF was drastically reversed to the left (decrease), with CMRO 2 shifted to the left (decrease) only in the animals treated with empty liposome, saline (data not shown), or LEH 0.4 ml/kg. OEF and CMRO 2 had decreased further in animals receiving empty liposome or saline (data not shown) 3 h later (T4), differing significantly from the LEH-treated groups (2 or 10 ml/kg), with OEF and CMRO 2 remaining central (preserved). There was no significant or consistent difference in CBF among the groups throughout the observation (T1-T4). OEF and CMRO 2 showed parallel changes at T3 and T4 and became different between control animals receiving empty liposome or saline and LEH-treated animals receiving 2 or 10 ml/kg LEH, with the animals treated with LEH at 0.4 ml/kg in between. Region of Interest. At T4, regional changes in CMRO 2 ( Fig. 2A) in three consecutive horizontal PET slices in the representative animals treated with empty liposome or LEH indicated that LEH preserved the cortex (open arrows, yellow line in MR image) better than the basal ganglia (red line in MR image) compared with empty liposome treatment (closed arrows), which showed a diffuse defect. The regional distribution of CMRO 2 at T4 (Fig. 2B, top) showed a significant reduction of cortical tissue with a mild reduction in CMRO 2 (71-100%) in all the LEH-treated groups of animals (0.4 ml/kg, P ϭ 0.047; 2 ml/kg, P ϭ 0.012; 10 ml/kg, P ϭ 0.012) compared with control animals receiving saline or empty liposome. In contrast, LEH at all the concentrations tested failed to protect the basal ganglia in terms of CMRO 2 (Fig.  2B, bottom) .
Morphological Examination. Samples from an LEHtreated animal (Fig. 3A) showed that the cortex was preserved compared with animals receiving empty liposome or saline, which showed morphological changes extending to the surrounding cortex. On the other hand, basal ganglia ‫,ء(‬ caudate nucleus; #, putamen in figure) were diffusely affected regardless of treatment. The integrated area of infarction (Fig. 3B) was reduced by 65.5% in animals treated with LEH at 2 ml/kg (P ϭ 0.028) and by 56.3% in monkeys receiving 10 ml/kg (P ϭ 0.026) compared with animals receiving saline. However, the treatment did not provide the same protection for basal ganglia.
Immunohistochemical Studies. Macroscopic observation of immunohistochemical staining in an LEH-treated monkey revealed a lack of MAP2 expression in the basal ganglia (Fig. 4A, top) , and this was associated with massive accumulation of LEH in consecutive slices (Fig. 4A, bottom) . Undetectable LEH was associated with normal MAP2 expression, and vice versa (LEH deposition associated with no MAP2 expression), at a microscopic level as well (Fig. 4B,  left) . This was in clear contrast to the intact hemisphere, where LEH was limited to the vascular lumen, without changes in MAP2 expression (Fig. 4B, right) . The boundary O 2 radioactivity ratio in each scan (T1-T4) for each treatment group. LEH administration slightly but consistently increased the radioactivity ratio, which remained elevated throughout the rest of the experiments. B, consecutive changes in CBF, OEF, and CMRO 2 distribution compared with preischemic control (T1) among animals treated with various doses of LEH and empty liposome (10 ml/kg) in the ischemic hemisphere from T2 through T4. Plotting of each group was slightly shifted along the horizontal axis to better present the SD bars in the order of animals receiving empty liposome (cross-hatched bar), LEH 0.4 ml/kg (thin bar), LEH 2 ml/kg (medium bar), or LEH 10 ml/kg (thick bar). Changes were similar in LEH-treated groups (2 or 10 ml/kg) in contrast to the control groups receiving empty liposome or saline (data not shown). Animals treated with LEH 0.4 ml/kg tended to fall between the two. 
Discussion
Whereas clinical trials using cell-free hemoglobin are all associated with adverse events (Natanson et al., 2008) , encapsulating hemoglobin to prevent extravasation as shown in previous studies (Ogata, 2000; Kawaguchi et al., 2007) can offer a better therapeutic option, prompting the current quantitative study on the acute phase of ischemic stroke. Although LEH caused systematic underestimation of OEF and CMRO 2 , correction by the common factor obtained in the contralateral intact hemisphere allowed us to analyze the regional change or distribution shift in the ischemic hemisphere. Thus, the present observations showed tolerance to LEH (up to 10 ml/kg) in all the animals, increased plasma O 2 Fig. 2 . A, three consecutive PET images (top, middle, or bottom), with reference to MR images (MRI) and to an intact animal (normal), in representative animals treated with empty liposome or LEH at T4. LEH treatment preserved cortical CMRO 2 (open arrows) compared with empty liposome treatment (closed arrows). Nonetheless, basal ganglia were not protected by either treatment. B, CMRO 2 distribution changes in the cortex (top) and basal ganglia (bottom) 3 h after reperfusion. Although cortical CMRO 2 was significantly preserved depending on the LEH doses, there was no protection in basal ganglia regardless of treatments or LEH doses. Fig. 3 . A, macroscopic view of H&E staining of coronal plane in three representative monkeys, treated with saline, empty liposome, or LEH. B, comparison of the integrated area of damage among the treatment groups. Whereas cortical damage was reduced significantly, by 65 or 56% with LEH 2 or 10 ml/kg compared with saline-treated controls, basal ganglia were not protected regardless of treatments.
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at ASPET Journals on October 17, 2017 jpet.aspetjournals.org Downloaded from content, and preserved cortical CMRO 2 (0.4 -10 ml/kg) associated with histological protection (2-10 ml/kg) early after ischemia and reperfusion if treated soon after MCAO.
To simulate the clinical threshold for reperfusion therapy (NINDS rt-PA Stroke Study Group, 1995; Lapchak, 2002) , MCAO was set at 3 h as in the other experimental protocols (Takamatsu et al., 2000 (Takamatsu et al., , 2001 Tsukada et al., 2004; Cui et al., 2006) . To maximize the potential benefit(s) of LEH, animals were treated as early as 5 min after MCAO. Nonetheless, there was no difference in O 2 metabolism for the first 2 h. This may serve as evidence that ischemia was similarly applied in both groups or that the amount of O 2 delivered during MCAO might have been so small that the resultant changes went undetected because of the signal-to-noise ratio of the current PET images (Cui et al., 2006) . After the typical ischemic patterns for the first 2 h (T2), reactive hyperemia with reversed CBF and suppressed OEF followed in all the groups immediately after reperfusion (T3). However, LEHtreated animals tended to have a less apparent reperfusion response (Takamatsu et al., 2000) , which was found to result in a significant reduction in the amount of cortical tissue associated with a mild CMRO 2 reduction 3 h later (T4). However, preserved CMRO 2 was not associated with a parallel increase in CBF but rather was associated with a relative preservation in OEF, suggesting persistence of ischemic tissue (Frykholm et al., 2000) , a metabolic pattern compatible with ischemic penumbra. This may indicate that there still remains a possibility of therapeutic intervention 3 h after reperfusion, being a better option than a parallel reduction in CBF and OEF in control animals, suggesting a complete loss of viability or definitive infarction. These differences in cortical O 2 metabolism were confirmed morphologically by the significantly lesser extension of infarction by LEH treatment.
Because the control animals had higher or comparable total arterial O 2 content, blood pressure, and plasma glucose levels, differences in these variables fail to account for the protection afforded by LEH. Because empty liposome is as ineffective as saline alone, O 2 -carrying capacity, or the presence of hemoglobin, in the liposome is vital. Nonetheless, it is puzzling that animals receiving 2 ml/kg LEH had equivalent protection in CMRO 2 to the monkeys receiving 10 ml/kg, with the level of LEH in circulation being 3 times higher. This may not be attributable to the highest LEH content in this group because its presence in plasma would not yield differential effects on the cortex versus basal ganglia only in the ischemic hemisphere (Fig. 2B) , parallel to the histological observation in terms of the extent of infarction (Fig. 3B) . Similar observations were made in our previous rodent studies in ischemic stroke (Kawaguchi et al., 2007) and in gastric wound healing (Okamoto et al., 2005) , where 2 ml/kg appeared to be as beneficial as 10 ml/kg LEH. Because the monkeys receiving 10 ml/kg had higher blood pressure, higher plasma 15 O 2 radioactivity, and similar total blood O 2 content during ischemia compared with the animals receiving 2 ml/kg, these variables do not account for a bell-shaped or plateaued doseresponse curve, leaving open the possibility that the O 2 supply of around 2 ml/kg, or 0.9% in volume in circulatory blood, might have been optimal. The presence of O 2 beyond the amount that ischemic tissues can use might facilitate the production of O 2 free radicals that could reverse the beneficial effect of increased O 2 availability. This may account for the undetermined effects of hyperbaric O 2 therapy, which increases dissolved O 2 in plasma as in the LEH treatment. Whereas linear O 2 dissociation characteristics physically release O 2 regardless of tissue PO 2 in hyperbaric O 2 therapy, hemoglobin in LEH releases O 2 more selectively when PO 2 is low because of the sigmoid O 2 dissociation characteristics. In our recent study , modified LEH with a higher O 2 affinity (P 50 O 2 ϭ 10 mm Hg) was found to be more protective, with a dose-response curve shifted to the right (1/5-1/25 doses are equally effective), than the current LEH with a lower O 2 affinity. Because these LEHs are otherwise identical, an optimal amount of O 2 supply, but not the presence of abundant O 2 or hemoglobin per se, may be important in the protection of the ischemic cortex.
The immunohistochemical staining for MAP2 and human hemoglobin for LEH showed a reciprocal presence of these proteins, suggesting that perfusion of LEH, but not deposition of LEH, provided protection macroscopically and microscopically. Neuronal tissue hemoglobin and its degradation products, as is the case with intracerebral hemorrhage, need to be assessed further because they may trigger oxygenradical-mediated processes and compound tissue injury later. The preferential protection in the cortex by LEH was similar in the current primate model and in rodent models (Kawaguchi et al., 2007; Fukumoto et al., 2009) , contrasting with the recent observation by Reddy and Labhasetwar (2009) of the nanoparticle-mediated administration of superoxide dismutase at reperfusion of MCA reducing the extent of cerebral infarction in basal ganglia in a rodent MCAO model. These observations considered together may suggest the existence of different perfusion patterns in the cortex and basal ganglia. This might partly be explained by the leptomeningeal system, which could function as collateral circulation during MCAO to foster O 2 delivery to the cortex. In contrast, the basal ganglia are irrigated by end-penetrating vessels and may not benefit similarly with improved collateral circulation or microcirculation. Moreover, at reperfusion, basal ganglia may be affected immediately and directly by reflux injury, which in turn could be attenuated by the superoxide dismutase-nanoparticle treatment (Reddy and Labhasetwar, 2009) .
Although the categorization is arbitrary, areas with a mild reduction in CMRO 2 (71-100% of preischemic value) beyond the least metabolic threshold (Frykholm et al., 2000) were reduced by LEH treatment in association with a relative preservation in OEF, suggesting the persistent ischemic tissue compatible with ischemic penumbra (Jones et al., 1981) , which remains amenable to therapeutic intervention 3 h after reperfusion. In contrast, more severe ischemic damage (Ͻ71% of preischemic value) below the least metabolic threshold (Frykholm et al., 2000) with a parallel reduction in CBF and OEF as in the control animals may suggest a total loss of tissue viability, leading to breached membrane integrity, LEH deposition, and histological damage (Tamura et al., 1980) as defined by H&E staining and loss of MAP2 from microtubules. Because the boundary between intact and ischemic tissue was sharp and narrow, the O 2 gradient may also be steep. Therefore, nanometer-sized LEH, but not RBCs, may flow with plasma through capillaries, patent even in the core of ischemia (Theilen et al., 1994) , to facilitate the O 2 supply by reducing the O 2 diffusion distance. We recently labeled LEH with an 18 F probe (Urakami et al., 2007) and found a concentric accumulation of radioactivity from the surrounding cortex toward the basal ganglia in a rodent MCAO model (Urakami et al., 2009 ) using a small animal PET system (Clairvivo; Shimadzu, Kyoto, Japan). Thus, it is plausible that LEH may perfuse with plasma, supplying O 2 to the cortex during ischemia to prevent ischemic penumbra from undergoing irreversible processes and thereby suppressing subsequent reperfusion injury. As a result, LEH may widen the current therapeutic time window of brain ischemia for thrombolytic therapy (NINDS rt-PA Stroke Study Group, 1995) and/or vascular intervention for reperfusion.
In conclusion, the results suggest that LEH, administered early after ischemic stroke in a nonhuman primate model, mitigates the resulting damage in the acute phase of ischemia and reperfusion injury. Although the late outcome is not clear from the current results, a longer-term observation up to 8 days after reperfusion shows these benefits to be persistent together with the neurological functions (AT Kawaguchi, M Haida, H Ohba, M Yamano, D Fukumoto, Y Ogata, and H Tsukada, manuscript in preparation). Because there is a lack of predictability of animal stroke models causing previous failures of translation of efficacy from nonhuman primates to humans, further studies with delayed administration of LEH, prolonged period of ischemia, or modifications of O 2 affinity may provide greater understanding of the mechanism(s) of action of LEH and thus suggest the use of artificial oxygen carriers for treating ischemic stroke.
